[HTML][HTML] Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
Chronic myeloid leukemia (CML) is the paradigm for targeted cancer therapy. RT-qPCR is
the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy based on …
the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy based on …
A review of the challenge in measuring and standardizing BCR-ABL1
S Yu, M Cui, X He, R Jing, H Wang - Clinical Chemistry and …, 2017 - degruyter.com
Breakpoint cluster region-Abelson (BCR-ABL1) translocation is the characteristic sign of
chronic myeloid leukemia (CML). The quantitation of BCR-ABL1 messenger RNA is …
chronic myeloid leukemia (CML). The quantitation of BCR-ABL1 messenger RNA is …
The case for laboratory developed procedures: quality and positive impact on patient care
KL Kaul, LM Sabatini, GJ Tsongalis… - Academic …, 2017 - journals.sagepub.com
An explosion of knowledge and technology is revolutionizing medicine and patient care.
Novel testing must be brought to the clinic with safety and accuracy, but also in a timely and …
Novel testing must be brought to the clinic with safety and accuracy, but also in a timely and …
Measurement of BCR‐ABL1 by RT‐qPCR in chronic myeloid leukaemia: findings from an International EQA Programme
S Scott, D Travis, L Whitby, J Bainbridge… - British Journal of …, 2017 - Wiley Online Library
Sequential measurement of BCR‐ABL 1 mRNA levels by reverse transcription quantitative
polymerase chain reaction (RT‐qPCR) is embedded in the management of patients with …
polymerase chain reaction (RT‐qPCR) is embedded in the management of patients with …
[HTML][HTML] Résultats du traitement de la leucémie myéloïde chronique par inhibiteurs de tyrosine kinase seuls ou associés à l'interféron
F Guilhot - Bulletin de l'Académie Nationale de Médecine, 2017 - Elsevier
La leucémie myéloïde chronique (LMC) est une pathologie de la cellule souche
hématopoïétique caractérisée par une prolifération importante de la lignée myéloïde. Une …
hématopoïétique caractérisée par une prolifération importante de la lignée myéloïde. Une …
[PDF][PDF] Biomolecular Detection and Quantification
abstract Chronic myeloid leukemia (CML) is the paradigm for targeted cancer therapy. RT-
qPCR is the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy …
qPCR is the gold standard for monitoring response to tyrosine kinase-inhibitor (TKI) therapy …
[HTML][HTML] Biología de la leucemia mieloide crónica
M Bianchini - Hematologia: Volumen 21-Extraordinario XXIII …, 2017 - books.google.com
La leucemia mieloide crónica (LMC) es una neoplasia mieloproliferativa de origen clonal
que se origina a partir de una lesión genética, el cromosoma Philadelphia (Ph1), que ocurre …
que se origina a partir de una lesión genética, el cromosoma Philadelphia (Ph1), que ocurre …